%0 Journal Article %1 ramakrishnan2021inhaled %A Ramakrishnan, Sanjay %A Nicolau, Dan V Jr %A Langford, Beverly %A Mahdi, Mahdi %A Jeffers, Helen %A Mwasuku, Christine %D 2021 %J Lancet Respiratory Medicine %K budesonide covid-19 %R 10.1016/S2213-2600(21)00160-0 %T Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

@article{ramakrishnan2021inhaled, added-at = {2021-04-19T19:07:21.000+0200}, author = {Ramakrishnan, Sanjay and Nicolau, Dan V Jr and Langford, Beverly and Mahdi, Mahdi and Jeffers, Helen and Mwasuku, Christine}, biburl = {https://www.bibsonomy.org/bibtex/233889623d1e986fe10a2d9b9056bc13c/fordham1}, description = {Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine}, doi = {10.1016/S2213-2600(21)00160-0}, interhash = {909301ae101b8f52ec7d991a4ec93d59}, intrahash = {33889623d1e986fe10a2d9b9056bc13c}, journal = {Lancet Respiratory Medicine }, keywords = {budesonide covid-19}, month = {April}, timestamp = {2021-04-19T19:07:21.000+0200}, title = {Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial }, year = 2021 }